African-American teen smokers: issues to consider for cessation treatment

E T Moolchan, I Berlin, M L Robinson, J L Cadet, E T Moolchan, I Berlin, M L Robinson, J L Cadet

Abstract

Previous reports have indicated ethnic differences in both tobacco-related morbidity and treatment outcome for smoking cessation among adults. We assessed smoking-related characteristics in African-American and non-African American teenagers applying to a cessation trial. 115 teens (15.9 +/- 1.8 years, 68% females, 27% African-American) responded via telephone to media ads. Self-reported sociodemographic, medical and smoking-related data were obtained to determine pre-eligibility for a full intake screen prior to trial participation. Compared to non-African American, African American teen applicants were older (16.4 +/- 1.7 years versus 15.6 +/- 1.6; p = 0.015), had lower Fagerström Test for Nicotine Dependence (FTND) scores (5.3 +/- 2.3 versus 6.1 +/- 1.8; p = 0.018, ANOVA controlling for age) and smoked fewer cigarettes on the weekend (27 +/- 16 versus 38 +/- 17; p = 0.001). African American teens reported similar duration of smoking (3.3 +/- 1.4 versus 3.1 +/- 1.5 years) and time elapsed between first cigarette ever smoked and daily smoking (0.7 +/- 0.9 versus 0.6 +/- 0.7 years). African American and non-African American teens had similar motivation to quit scores and frequency of reported health problems (e.g., asthma, psychiatric conditions). These data suggest that cessation treatment programs designed for African American youth should include lower Fagerstrom-defined levels, and possibly other criteria for tobacco dependence. These observations also highlight the importance of ethnocultural issues in treatment research programs.

References

    1. Am J Public Health. 1990 Sep;80(9):1053-6
    1. Br J Addict. 1991 Sep;86(9):1119-27
    1. Am J Public Health. 1989 Feb;79(2):176-81
    1. Am Heart J. 1984 Sep;108(3 Pt 2):759-69
    1. Addict Behav. 1978;3(3-4):235-41
    1. Tob Control. 2000 Mar;9(1):64-70
    1. Ear Nose Throat J. 1990 Nov;69(11):763-5
    1. Pediatrics. 1999 Jul;104(1 Pt 1):35-42
    1. Arch Pediatr Adolesc Med. 1999 Mar;153(3):313
    1. JAMA. 1998 Jul 8;280(2):179-80
    1. JAMA. 1998 Jul 8;280(2):152-6
    1. JAMA. 1998 Jul 8;280(2):135-9
    1. Am J Prev Med. 1998 Feb;14(2):138-42
    1. Am J Prev Med. 1998 Feb;14(2):130-7
    1. Tob Control. 1997 Winter;6(4):306-10
    1. MMWR Morb Mortal Wkly Rep. 1998 Apr 3;47(12):229-33
    1. Pediatrics. 1996 Oct;98(4 Pt 1):659-67
    1. MMWR Morb Mortal Wkly Rep. 1994 Oct 21;43(41):745-50
    1. JAMA. 1991 Dec 11;266(22):3145-8
    1. Am J Public Health. 1991 Nov;81(11):1498-505
    1. Addict Behav. 1990;15(1):73-80

Source: PubMed

3
Se inscrever